Atara Biotherapeutics, Inc. (ATRA) › Total LiabilitiesAtara Biotherapeutics, Inc. (ATRA) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2013: $1.75M2014: $2.94M2015: $9.88M2016: $10.18M2017: $39.91M2018: $52.98M2019: $52.16M2020: $125.78M2021: $188.51M2022: $249.78M2023: $264.74M2024: $206.38M2025: $58.74M$58.74M2013Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$58.74M-71.5%2024$206.38M-22.0%2023$264.74M+6.0%2022$249.78M+32.5%2021$188.51M+49.9%2020$125.78M+141.1%2019$52.16M-1.5%2018$52.98M+32.7%2017$39.91M+292.2%2016$10.18M+3.1%2015$9.88M+235.9%2014$2.94M+67.6%2013$1.75M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share